The theory of the sick breast lobe and the possible consequences

International Journal of Surgical Pathology

Volumn 15, Issue 4, 2007, Pages 369-375

  Tot, Tibor ^a  

^a FALUN HOSPITAL   (Sweden)

Author keywords

Breast; Breast cancer; Cancer prevention; Hypothesis; Screening; Sick lobe

Indexed keywords

BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST METASTASIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; EPIGENETICS; GENETIC PREDISPOSITION; GENETICS; HISTOLOGY; HUMAN; MORPHOLOGY; MORTALITY; MUTATION; NOCICEPTIVE STIMULATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; UTERINE CERVIX CANCER;

BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS;

EID: 34748890616     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896907302225     Document Type: Review

References (55)

1. Hartman LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999 ; 340: 77-84.
2. Olopade OI, Artioli G. Efficacy of risk-reducing salpyngo-oophorectomy in women with BRCA-1 and BRCA-2 mutations. Breast J. 2004 ; 10S: S5 - S9.
3. Michels K., Ekbom A. Caloric restriction and incidence of breast cancer. JAMA. 2004 ; 291: 1226-1230.
4. Fisher B., Nostatino JP, Wickerman DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998 ; 90: 1371-1388.
5. Cuzick J., Forbes J., Edwards R.,, et al. the IBIS Investigators. First results from the International Breast Cancer intervention Study (IBIS-I): a randomised prevention trial. Lancet. 2002 ; 360: 817-824.
6. Cady B. How to prevent invasive breast cancer: detect and excise duct carcinoma in situ. J Surg Oncol. 1998 ; 69: 60-62.
7. Smith RA, Gabe R., Tabar L., Yen AM, Chen TH The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004 ; 42: 793-806.
8. The Swedish Organized Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with expanded data. Cancer Epidemiol Biomarkers Prev. 2006 ; 15: 45-51.
9. Hortobagy GN Trastuzumab in the treatment of breast cancer. N Engl J Med. 2005 ; 353: 1734-1436.
10. Boyle P., Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005 ; 16: 481-488.
11. Kawamura T., Sobue T. Comparison of breast cancer mortality in five countries: France, Italy, Japan, the UK and the USA from the WHO Mortality Database (1960-2000). Jpn J Clin Oncol. 2005 ; 35: 758-759.
12. Centre for Epidemiology, National Board of Health and Welfare, Stockholm, Sweden. Homepage of the Swedish Ministry of Health. Available at: www.sos.se/epc. Accessed October 15, 2006.
13. Nuovo J., Melnikow J., Willan AR, Chan BK Treatment outcomes for squamous intraepithelial lesions. Int J Gynaecol Obstet. 2000 ; 68: 25-33.
14. Tot T. Correlating the ground truth of mammographic histology with the success or failure of imaging. Technol Cancer Res Treat. 2005 ; 4: 23-28.
15. Tot T. DCIS, cytokeratins and the theory of the sick lobe. Virchows Arch. 2005 ; 447: 1-8.
16. Dean M. Cancer stem cells: redefining the paradigm of cancer treatment strategies. Mol Interv. 2006 ;6: 140-148.
17. Ohtake T., Abe R., Kimijima I., et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer. 1995 ; 76: 32-45.
18. Rosen PP Rosens's Breast Pathology. Philadelphia, Pa: Lippincott Williams &Wilkins ; 2001.
19. Tot T., Tabár L., Dean PB The pressing need for better mammographic-pathologic correlation of many variations in normal breast anatomy. Virchows Arch. 2000 ; 437: 338-344.
20. Going JJ, Moffat DF Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions. J Pathol. 2004 ; 203: 538-544.
21. Going JJ, Mohun TJ Human breast duct anatomy, the "sick lobe" hypothesis and intraductal approaches to breast cancer. Breast Cancer Res Treat. 2006 ; 97: 285-291.
22. Mai KT, Yazdi HM, Burns BF, Perkins DG Pattern of distribution of intraductal and infiltrating ductal carcinoma: three-dimensional study using serial coronal giant sections of the breast. Hum Pathol. 2000 ; 31: 464-474.
23. Middleton LP, Vlastos G., Mirza NQ, Eva S., Sahin AA Multicenric mammary marcinoma, evidence of monoclonal proliferation. Cancer. 2002: 94: 1910-1916.
24. Gallager HS, Martin JE The study of mammary carcinoma by mammography and whole organ sectioning. Cancer. 1969 ; 23: 855-873.
25. Holland R., Hendricks JH, Vebeek AL, Mravunac M., Schuurman S., Stekhoven JH Extent, distribution, and mammographic/histological correlation of breast ductal carcinoma in situ. Lancet. 1990 ; 335: 519-522.
26. Faverly DRG, Hendricks JHCL, Holland R. Breast carcinoma of limited extent. Frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001 ; 91: 647-659.
27. Andersen JA, Blichert-Toft M., Dyreborg U. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment. Eur J Surg Oncol. 1987 ; 13: 105-111.
28. Tot T., Tabár L., Dean PB Practical Breast Pathology. New York, NY: Thieme ; 2002: 116-123.
29. Jackson PA, Merchant W., McCormick CJ, Cook MG A comparison of large block macrosectioning and conventional techniques in breast pathology. Virchows Arch. 1994 ; 425: 243-248.
30. Tot T. The subgross morphology of normal and pathologically altered breast tissue. In: Suri JS, Rangayyan RM, eds. Recent Advances in Breast Imaging, Mammography and Computer-Aided Diagnosis of Breast Cancer. Bellingham, Wash: SPIE Press ; 2006: 1-49.
31. Tot T., Tabár L. Radio-pathologic correlation of ductal carcinoma in situ of the breast using two- and three-dimensional large histologic sections. Semin Breast Dis. 2005 ; 8: 144-151.
32. Millis RR, Ryder K., Fentiman JS Ductal in situ component and prognosis in invasive mammary carcinoma. Breast Cancer Res Treat. 2004 ; 84: 197-198.
33. Gupta SK, Douglas-Jones AG, Fenn N., Morgan JM, Mansel RE The clinical behaviour of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer. 1997 ; 80: 1740-1745.
34. Tabár L., Chen HH, Duffy SW, et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet. 2000 ; 355: 429-433.
35. Michels KB, Xue F. Role of birthweight in the etiology of breast cancer. Int J Cancer. 2006 ; 119: 2007-2025.
36. Cerhan JR, Sellers TA, Janney CA, Pankratz VS, Brandt KR, Vachon CM Prenatal and perinatal correlates of adult mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2005 ; 14: 1502-1508.
37. Baik I., Devito WJ, Ballen K., et al. Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer. Cancer Res. 2005 ; 65: 358-363.
38. Savarese TM, Low HP, Baik I., Strohsnitter WC, Hsieh CC Normal breast stem cells, malignant breast stem cells and the perinatal origin of breast cancer. Stem Cell Rev. 2006 ; 2: 103-110.
39. Sanders ME, Schyler PA, Dupont WD, Page DL The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005 ; 103: 2481-2484.
40. Goldstein NS, Vicini FA, Hunter S, et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy. Am J Clin Pathol. 2005 ; 123: 679-689.
41. Stratton MR, Collins N., Lakhani SR, Sloane JP Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol. 1995 ; 175: 195-201.
42. Farabegoli F., Champeme MH, Bieche I., et al. Genetic pathways in the evolution of breast ductal carcinoma in situ. J Pathol. 2002: 196: 280-286.
43. Buerger H., Otterbach F., Simon R., et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol. 1999 ; 187: 396-402.
44. Lakhani SR, Collins N., Sloane JP, Stratton MR Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol. 1995, 48: M74 - M78.
45. Vos CB, Cleton-Jansen AM, Berx G., et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 1997 ; 76: 1131-1133.
46. Lu YJ, Osin P., Lakhani SR, Di Palma S., Gusterson BA, Shipley JM Comparative genomic hybridisation analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res. 1998 ; 58: 4721-4727.
47. Buerger H., Simon R., Schafer KL, et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol. 2000 ; 53: 118-121.
48. Lakhani SR, Collins N., Stratton MR, Sloane JP Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol. 1995 ; 48: 611-615.
49. Simpson PT, Gale T., Reis Filho JS, et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 2005 ; 29: 734-746.
50. Lakhani SR, Slack DN, Hamoudi RA, Collins N., Stratton MR, Sloane JP Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest. 1996 ; 74: 129-135.
51. Lakhani SR, Chaggar R., Davies S., et al. Genetic alterations in "normal" luminal and myoepithelial cells of the breast. J Pathol. 1999 ; 189: 496-503.
52. Deng G., Lu Y., Zlotnikov G., Thor AD, Smith HS Loss of heterozygosity in normal tissue adjacent to breast carcinoma. Science. 1996 ; 274: 2057-2059.
53. Clark CL, Sandle J., Jones AA, Sofronis A., Patani NR, Lakhani SR Mapping loss of heterozygosity in normal human breast cells from BRCA 1/2 carriers. Br J Cancer. 2006 ; 95: 515-519.
54. Yan PS, Venkataramu C., Ibrahim A., et al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res. 2006 ; 12: 6626-6636.
55. Wellings SR, Jensen HM, Marcum RG An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975 ; 55: 231 - 273.